Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd..
Real, source-linked trial activity for Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.: 4 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE3 2PHASE1 1PHASE1/PHASE2 1
Newest Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | A Pharmacokinetic Study of HDM1005 Injection at Different Injection Si | Ph 1 | ACTIVE_NOT_RECRUITING | ↗ |
| 16d ago | A Study of HDM2017 Combination Therapy in Advanced Colorectal Cancer | Ph 1/Ph 2 | RECRUITING | ↗ |
| 20d ago | A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 25d ago | A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.